chitosan has been researched along with Grippe in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hao, C; Huang, L; Li, C; Luo, Y; Sun, L; Wang, S; Wang, W; Zhang, Y | 1 |
| Chaisuwirat, P; Ellison, D; Fernandez, S; Macareo, L; Midoeng, P; Rungrojcharoenkit, K; Sunintaboon, P; Ubol, S | 1 |
| Kim, EH; Kim, K; Lim, YT; Nguyen, TQ; Poo, H; Shim, SM; Sung, MH; Webby, R; Yang, J | 1 |
| Dabaghian, M; Ebrahimi, SM; Latifi, AM; NajmiNejad, H; Tebianian, M | 1 |
| Catchpole, A; Cox, R; de Waal, L; Hinchcliffe, M; Knight, A; Lambkin-Williams, R; Lapini, G; Mann, AJ; Montomoli, E; Noulin, N; Osterhaus, AD; Oxford, JS; Piccirella, S; Smith, A; Stittelaar, KJ; Veldhuis Kroeze, EJ | 1 |
| Ma, G; Su, Z; Wang, Y; Wei, W; Wu, J; Wu, Y; Zhou, M | 1 |
6 other study(ies) available for chitosan and Grippe
| Article | Year |
|---|---|
The inhibition effects and mechanisms of sulfated chitooligosaccharides on influenza A virus in vitro and in vivo.
Topics: Animals; Antiviral Agents; Chitosan; Humans; Influenza A virus; Influenza, Human; Mice; Oligosaccharides; Sulfates | 2022 |
Development of an adjuvanted nanoparticle vaccine against influenza virus, an in vitro study.
Topics: Adjuvants, Immunologic; Animals; Cell Line; Cells, Cultured; Chitosan; Dogs; Drug Carriers; Hemagglutinin Glycoproteins, Influenza Virus; Humans; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Madin Darby Canine Kidney Cells; Nanoparticles; Nucleocapsid Proteins; Orthomyxoviridae Infections; RNA-Binding Proteins; Viral Core Proteins | 2020 |
Poly-γ-glutamic acid/chitosan nanogel greatly enhances the efficacy and heterosubtypic cross-reactivity of H1N1 pandemic influenza vaccine.
Topics: Adjuvants, Immunologic; Animals; Antigen Presentation; Antigens, Viral; Chitosan; Cross Reactions; Dendritic Cells; Disease Models, Animal; Ferrets; Histocompatibility Antigens Class I; Humans; Immunity, Cellular; Immunogenicity, Vaccine; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Mice; Orthomyxoviridae Infections; Phagosomes; Polyglutamic Acid | 2017 |
Nasal vaccination with r4M2e.HSP70c antigen encapsulated into N-trimethyl chitosan (TMC) nanoparticulate systems: Preparation and immunogenicity in a mouse model.
Topics: Adjuvants, Immunologic; Administration, Intranasal; Animals; Antibodies, Viral; Bronchoalveolar Lavage Fluid; Cell Proliferation; Chitosan; Disease Models, Animal; Drug Carriers; Female; HSP72 Heat-Shock Proteins; Humans; Immunity, Cellular; Immunity, Humoral; Immunoglobulin A; Immunoglobulin G; Influenza Vaccines; Influenza, Human; Interferon-gamma; Leukocytes, Mononuclear; Mice, Inbred BALB C; Nanoparticles; Serum; Survival Analysis; Treatment Outcome; Vaccines, Synthetic; Viral Matrix Proteins | 2018 |
Intranasal H5N1 vaccines, adjuvanted with chitosan derivatives, protect ferrets against highly pathogenic influenza intranasal and intratracheal challenge.
Topics: Adjuvants, Immunologic; Administration, Intranasal; Animals; Animals, Outbred Strains; Antibodies, Neutralizing; Antibodies, Viral; Chitosan; Dogs; Ferrets; Humans; Influenza A Virus, H5N1 Subtype; Influenza Vaccines; Influenza, Human; Madin Darby Canine Kidney Cells; Male; Nose; Trachea; Vaccination; Vaccine Potency; Viral Load | 2014 |
Thermal-sensitive hydrogel as adjuvant-free vaccine delivery system for H5N1 intranasal immunization.
Topics: Adjuvants, Immunologic; Administration, Intranasal; Animals; Antigens, Viral; CD8-Positive T-Lymphocytes; Cell Proliferation; Chitosan; Humans; Hydrogels; Immunity, Mucosal; Immunoglobulin G; Influenza A Virus, H5N1 Subtype; Influenza Vaccines; Influenza, Human; Materials Testing; Mice; Nasal Mucosa; Temperature; Vaccination | 2012 |